CD4 and malaria: In WHO 2021, cotrimoxazole prophylaxis is recommended for PWH with a CD4 + count < 350 cells/mm3, clinical stage 3 or 4, or to any PWH in settings with high prevalence of malaria or severe bacterial infection.